Directed share issue in Azelio AB (SE) — SEK 596 million Cleantech, Renewables & Infrastructure Directed share issue in Azelio AB (SE) — SEK 596 million
Directed share issue in Oncopeptides AB (SE) — SEK 1,106 million Healthcare Directed share issue in Oncopeptides AB (SE) — SEK 1,106 million
Private placement in Aker Clean Hydrogen (NO) and subsequent admittance for trading on Euronext Growth Oslo – NOK 3.45 billion Cleantech, Renewables & Infrastructure Private placement in Aker Clean Hydrogen (NO) and subsequent admittance for trading on Euronext Growth Oslo – NOK 3.45 billion
Private placement in Flyr AS (NO) and subsequent admittance for trading on Euronext Growth Oslo – NOK 600 million Business Services Private placement in Flyr AS (NO) and subsequent admittance for trading on Euronext Growth Oslo – NOK 600 million
Acquisition of Moonfrog Labs Pvt. Ltd (IN) by Stillfront Group AB (SE) — USD 90 million TMT Acquisition of Moonfrog Labs Pvt. Ltd (IN) by Stillfront Group AB (SE) — USD 90 million
Initial public offering of Cint Group AB (SE) on Nasdaq Stockholm – SEK 5,962 million TMT Initial public offering of Cint Group AB (SE) on Nasdaq Stockholm – SEK 5,962 million
Private placement and Listing of Desenio Group AB — SEK 4.5 billion Consumer & Retail Private placement and Listing of Desenio Group AB — SEK 4.5 billion
Directed share issue in Nel ASA (NO) — NOK 1,225 million Industrials Directed share issue in Nel ASA (NO) — NOK 1,225 million
Directed share issue in Remedy Entertainment Oyj (FI) — EUR 41.5 million TMT Directed share issue in Remedy Entertainment Oyj (FI) — EUR 41.5 million
Directed share issue in Nordic Nanovector ASA (NO) — NOK 361 million Healthcare Directed share issue in Nordic Nanovector ASA (NO) — NOK 361 million
Public offer to the shareholders of Recipharm AB – SEK 25.0 billion Healthcare Public offer to the shareholders of Recipharm AB – SEK 25.0 billion
Bond tap issue by Humble Group AB (SE) — SEK 200 million Consumer & Retail Bond tap issue by Humble Group AB (SE) — SEK 200 million